Drugs Made In America Acquisition II Corp.

DMIIR is a blank check company incorporated in 2024 and headquartered in Fort Lauderdale, Florida. The company currently has no significant operating business and exists primarily as a vehicle for identifying and completing a business combination. It is seeking to merge with, acquire, or otherwise combine with one or more operating businesses through share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar transaction structures.

The company has not yet identified a target business combination partner and therefore generates no revenue. No business segments or revenue streams are currently active. As a newly formed special purpose acquisition company, DMIIR's operational scale, employee count, and geographic footprint remain minimal pending the completion of a prospective business combination transaction.